Product Recalls in Florida

Product recalls affecting Florida — including food, drugs, consumer products, medical devices, and vehicles distributed to Florida. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,940 recalls have been distributed to Florida in the last 12 months.

55,837 total recalls
2,940 in last 12 months

Showing 801820 of 13,925 recalls

DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· Regenerative Processing Plant, LLC

Recalled Item: LITE Regener-Eyes Recalled by Regenerative Processing Plant, LLC Due to Lack...

The Issue: Lack of Sterility Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Amerisource Health Services...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Amerisource Health...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Amerisource Health...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Amerisource Health Services...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Aurobindo Pharma USA Inc

Recalled Item: Nebivolol Tablets Recalled by Aurobindo Pharma USA Inc Due to CGMP...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 4, 2024· PD-Rx Pharmaceuticals, Inc.

Recalled Item: DULoxetine DR USP Recalled by PD-Rx Pharmaceuticals, Inc. Due to CGMP...

The Issue: CGMP Deviations: the presence of a Nitrosamine Drug Substance Related...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 4, 2024· AvKARE

Recalled Item: Nitrofurantoin Capsules Recalled by AvKARE Due to Failed Dissolution...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 2, 2024· RemedyRepack Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by RemedyRepack Inc. Due to...

The Issue: CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2024· Curium US, LLC

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sestamibi Injection Recalled by...

The Issue: Lack of Assurance of Sterility; Improper crimps on vials impacting the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 25, 2024· Macleods Pharmaceuticals Ltd

Recalled Item: Olanzapine Tablets Recalled by Macleods Pharmaceuticals Ltd Due to Failed...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Provepharm Inc.

Recalled Item: Dihydroergotamine Mesylate Injection Recalled by Provepharm Inc. Due to...

The Issue: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Jubilant Draximage Inc., dba Jubilant Radiopharma

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection...

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund